Plotkin, Scott

AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients

Batchelor, T. T., Sorensen, A. G., di Tomaso, E., Zhang, W.-T., Duda, D. G., Cohen, K. S., Kozak, K. R., Cahill, D. P., Chen, P.-J., Zhu, M., et al. (2007) · Cancer Cell

Angiogenesis and VEGF in CancerGlioma Diagnosis and Treatment

Cited by 1,769

Phase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma

Batchelor, T. T., Duda, D. G., di Tomaso, E., Ancukiewicz, M., Plotkin, S. R., Gerstner, E., Eichler, A. F., Drappatz, J., Hochberg, F. H., Benner, T., et al. (2010) · Journal of Clinical Oncology

Glioma Diagnosis and TreatmentAngiogenesis and VEGF in Cancer

Cited by 520

Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism.

Banks, W. A., Ortiz, L., Plotkin, S. R., & Kastin, A. J. (1991) · The Journal of Pharmacology and Experimental Therapeutics

Barrier Structure and Function StudiesNeuroinflammation and Neurodegeneration Mechanisms

Cited by 474

Mind–body therapy via videoconferencing in patients with neurofibromatosis: An RCT

Vranceanu, A.-M., Riklin, E., Merker, V. L., Macklin, E. A., Park, E. R., & Plotkin, S. R. (2016) · Neurology

Mindfulness and Compassion InterventionsTelemedicine and Telehealth Implementation

Cited by 85

Virtual mind-body treatment for geographically diverse youth with neurofibromatosis: A pilot randomized controlled trial

Lester, E., DiStefano, S., Mace, R., Macklin, E., Plotkin, S., & Vranceanu, A.-M. (2020) · General Hospital Psychiatry

Neurofibromatosis and Schwannoma CasesTelemedicine and Telehealth Implementation

Cited by 22